CIMS Global

CIMS Global is a leader in eClinical solutions, boasting over 16 years of industry experience and involvement in more than 1600 global clinical trials. The company is renowned for its proprietary technology, supported by published research, which enhances the efficiency and effectiveness of clinical trials.

One of their key offerings is the DMC-HUB, which provides an independent working environment with centralized management for the IDMC process. Another innovative tool is eBinder™, designed to improve clinical trial efficiency by automatically uploading patient information into a secure database, eliminating manual data entry. eBinder™ can be integrated into EDC and SDC systems or used as a standalone tool.

CIMS Global's suite of Innovative Solutions pushes the boundaries of clinical trial capabilities. These solutions provide insights that predict trial outcomes and automate site data capture processes, aligning with their mission to reshape the future of clinical trials.

The company's eClinical Solutions include EDC and IWRS systems integrated with CIMS DDM™, forming a closed system capable of running complex statistical and mathematical computations. This system can significantly reduce the time required to determine a drug's efficacy.

Key Features and Benefits:

• Trial Optimization: Maximize the success of ongoing trials.
• Early Termination: Alerts for futility analysis and trial modifications.
• Drug Safety Detection: Continuous monitoring and signal detection.
• Dose Selection: Optimize Phase 2/3 trials by identifying potential doses for Phase 3.
• Population Selection: Identify effective subpopulations for personalized medicine.
• Sample Size Re-estimation: Estimate optimal sample sizes for success.
• Model Checking: Verify trial assumptions.

CIMS Global is committed to transforming the clinical trial experience, offering solutions that can significantly reduce trial costs and enhance drug development processes.